Brain Aneurysm Treatment Market Expected to Register a Heavy CAGR of 5.4% by 2023
© Karishma s
The report gives detail analysis of the market structure along with forecast, market size & share, different segments and developing trends of the industry.
Brain Aneurysm Treatment Market - Scenario
Brain Aneurysm is an abnormal dilation of arteries in the brain which finally results in the weakening of inner muscular layer of the blood vessel wall.
Over time, blood flow within the artery starts pushing the thin portion of the wall and ruptures it. There are number of factors that contribute to the occurrence of brain aneurysms, such as cigarette smoking, injury or trauma, blood infections, and many others.
GET FREE SAMPLE REPORT AT https://www.marketresearchfuture.com/sample_request/4561
Brain Aneurysm Treatment Market –Leading Industry Players
Medtronic Plc.
Codman & Shurtleff, Inc.
Raumedic AG
Vittamed, Sophysa Ltd.
MicroPort Scientific Corporation,
Orsan Medical Technologies
Spiegelberg GmbH
Johnson & Johnson
Sophysa Ltd
HaiWeiKang
Individuals harboring a brain aneurysm can be diagnosed by various techniques, such as Computed Tomography (CT) scan, Computed Tomography Angiogram (CTA) scan, Magnetic Resonance Angiography (MRA), cerebral angiogram, and many others.
A number of factors such as, increasing prevalence of brain aneurysms, advancement in surgical techniques, rising occurrence of high blood pressure, and increasing healthcare funding by government bodies are propelling the growth of Brain Aneurysm Treatment market.
It is estimated that Brain Aneurysm Treatment market is expected to grow at a CAGR 5.4% during the forecast period of 2017-2023.
According to the Brain Aneurysm Foundation, occurrence of familial aneurysms among subarachnoid hemorrhage patients is 6% to 20%. Despite these drivers, there are some issues associated with Brain Aneurysm Treatment market.
High cost of management for aneurysmal subarachnoid hemorrhage, and unknown symptoms of unruptured brain aneurysm may hinder the growth of market to an extent.
Brain Aneurysm Foundation states that Brain aneurysms are mostly prevalent at the age of 35 – 60 years whereas aneurysmal hemorrhagic stroke is more common in people aged 50 years.
Brain Aneurysm Treatment Market -Regional Analysis
The Americas dominates the Brain Aneurysm Treatment market owing to the increasing prevalence of brain aneurysm. According to the 2017 study published in Surg Neurol Int., it is found that more than 3% population of the United States i.e. nearly 10 million individuals are living with brain aneurysm.
Europe holds the second position in brain aneurysm treatment market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region.
According to a research study published in BMJ Open, it is found that Unruptured Intracranial Aneurysms (UIAs) is one of the most common cerebrovascular conditions in Germany. It is also estimated that nearly 1.6 million individuals in Germany are suffering from Unruptured intracranial aneurysms (UIAs).
OBTAIN REPORT DETAILS AT https://www.marketresearchfuture.com/reports/brain-aneurysm-treatment-market-4561
Brain Aneurysm Treatment Market -Segmentation
The Brain Aneurysm Treatment market is segmented on the basis of type, Condition, and end-user.
On the basis of type, market is segmented into surgery and medication. Surgery is further classified into surgical clipping, endovascular coiling, flow diverter, and others. Sub-segmentation of flow diverter includes pipeline embolization device, silk flow diverter (SILK), and surpass flow diverter (SURPASS).
Sub-segmentation of medication includes anti-seizure medications, analgesics, calcium channel blockers, anti-hypertensives, anti-emetics, antacids, stool softeners, and others.
Brain Aneurysm Treatment Market -Some Points from Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
..Continued
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Brain Aneurysm Treatment Market - Scenario
Brain Aneurysm is an abnormal dilation of arteries in the brain which finally results in the weakening of inner muscular layer of the blood vessel wall.
Over time, blood flow within the artery starts pushing the thin portion of the wall and ruptures it. There are number of factors that contribute to the occurrence of brain aneurysms, such as cigarette smoking, injury or trauma, blood infections, and many others.
GET FREE SAMPLE REPORT AT https://www.marketresearchfuture.com/sample_request/4561
Brain Aneurysm Treatment Market –Leading Industry Players
Medtronic Plc.
Codman & Shurtleff, Inc.
Raumedic AG
Vittamed, Sophysa Ltd.
MicroPort Scientific Corporation,
Orsan Medical Technologies
Spiegelberg GmbH
Johnson & Johnson
Sophysa Ltd
HaiWeiKang
Individuals harboring a brain aneurysm can be diagnosed by various techniques, such as Computed Tomography (CT) scan, Computed Tomography Angiogram (CTA) scan, Magnetic Resonance Angiography (MRA), cerebral angiogram, and many others.
A number of factors such as, increasing prevalence of brain aneurysms, advancement in surgical techniques, rising occurrence of high blood pressure, and increasing healthcare funding by government bodies are propelling the growth of Brain Aneurysm Treatment market.
It is estimated that Brain Aneurysm Treatment market is expected to grow at a CAGR 5.4% during the forecast period of 2017-2023.
According to the Brain Aneurysm Foundation, occurrence of familial aneurysms among subarachnoid hemorrhage patients is 6% to 20%. Despite these drivers, there are some issues associated with Brain Aneurysm Treatment market.
High cost of management for aneurysmal subarachnoid hemorrhage, and unknown symptoms of unruptured brain aneurysm may hinder the growth of market to an extent.
Brain Aneurysm Foundation states that Brain aneurysms are mostly prevalent at the age of 35 – 60 years whereas aneurysmal hemorrhagic stroke is more common in people aged 50 years.
Brain Aneurysm Treatment Market -Regional Analysis
The Americas dominates the Brain Aneurysm Treatment market owing to the increasing prevalence of brain aneurysm. According to the 2017 study published in Surg Neurol Int., it is found that more than 3% population of the United States i.e. nearly 10 million individuals are living with brain aneurysm.
Europe holds the second position in brain aneurysm treatment market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region.
According to a research study published in BMJ Open, it is found that Unruptured Intracranial Aneurysms (UIAs) is one of the most common cerebrovascular conditions in Germany. It is also estimated that nearly 1.6 million individuals in Germany are suffering from Unruptured intracranial aneurysms (UIAs).
OBTAIN REPORT DETAILS AT https://www.marketresearchfuture.com/reports/brain-aneurysm-treatment-market-4561
Brain Aneurysm Treatment Market -Segmentation
The Brain Aneurysm Treatment market is segmented on the basis of type, Condition, and end-user.
On the basis of type, market is segmented into surgery and medication. Surgery is further classified into surgical clipping, endovascular coiling, flow diverter, and others. Sub-segmentation of flow diverter includes pipeline embolization device, silk flow diverter (SILK), and surpass flow diverter (SURPASS).
Sub-segmentation of medication includes anti-seizure medications, analgesics, calcium channel blockers, anti-hypertensives, anti-emetics, antacids, stool softeners, and others.
Brain Aneurysm Treatment Market -Some Points from Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
..Continued
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com